Eli Lilly and Company (LLY)

$839.87 +20.02 (2.44%)
Market Cap 775.95B
Revenue (ttm) 45.04B
Net Income (ttm) 10.59B
EPS (ttm) N/A
PE Ratio 51.11
Forward PE 35.58
Profit Margin 23.51%
Debt to Equity Ratio 2.24
Volume 5,088,500
Avg Vol 5,117,552
Day's Range N/A - N/A
Shares Out 946.46M
Stochastic %K 94%
Beta 0.47
Analysts Strong Sell
Price Target $902.75

Company Profile

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. It also provides oncolog...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 317 276 2000
Address:
Lilly Corporate Center, Indianapolis, United States
TalkMarkets
TalkMarkets Oct. 4 at 8:00 PM
Viking Therapeutics #Stock: A Stumble Or The #Setup Of The Decade? $LLY $NVO $VKTX Also $MRK $PFE https://talkmarkets.com/content/stocks--equities/viking-therapeutics-stock-a-stumble-or-the-setup-of-the-decade?post=526441&userid=123969
0 · Reply
Skipper6
Skipper6 Oct. 4 at 6:31 PM
$VKTX ...Lilly needs to buy Viking and get it over with, they'll be kicking themselves if someone else grabs them! $LLY share price will double and they will quickly be a trillion dollar mc business!! Go Viking!
0 · Reply
GreenEnergy2022
GreenEnergy2022 Oct. 4 at 4:42 PM
$ALT The cT1 data we presented was extremely good! $MDGL $LLY $AKRO
0 · Reply
MyDynastyLife
MyDynastyLife Oct. 4 at 3:35 PM
$LLY ❤️ this ticker
1 · Reply
Blueville
Blueville Oct. 4 at 3:09 PM
$HOOD $LLY $TSLA The top performing options lottos of the week from Sept 29 - Oct 3. #ConsistentProfits #BluevilleCapital
0 · Reply
Synaptric
Synaptric Oct. 4 at 2:37 PM
$NOW $TMO $LLY $META $PEP Year-to-date high in above-cloud count. The week’s developments highlight a constructive underlying message: rotation into new sectors is broadening leadership and reinforcing structural strength across the market. With healthcare joining technology in driving gains, the Cloud Watch indicators suggest resilience remains the defining feature of this rally.
0 · Reply
ChartGuysDan
ChartGuysDan Oct. 4 at 2:20 PM
XBI XLV seeing rotation. Trump tipping Off Trades. Scouting swing shorts in quantum. https://www.chartguys.com/watch?v=FEatasR0T1I $QBTS $RGTI $TSLA $LLY $SLV
0 · Reply
Synaptric
Synaptric Oct. 4 at 2:05 PM
$NOW $TMO $LLY $META $PEP U.S. equities resumed their advance this week, with the NASDAQ 100 rising 1.2% and the S&P 500 gaining 1.1%. Investors looked past headlines and instead embraced a mix of optimism, deal activity, and sector rotation. Notably, the Cloud Watch breadth measure climbed to a year-to-date high, with 22 constituents now trading above their weekly Ichimoku Clouds. This rising count underscores a broad structural resilience that continues to underpin the market. Rotation into healthcare stood out as a defining theme. Eli Lilly and Thermo Fisher Scientific both vaulted from below-cloud to above-cloud status, reflecting investor enthusiasm for the sector. Such rotation is an encouraging sign of market health, as leadership expands beyond the usual names. Subscribe here: .https://cloudwatch.beehiiv.com/subscribe. https://cloudwatch.beehiiv.com/p/market-rotation-signals-broad-structural-strength-cloud-watch-10-3-25
0 · Reply
Omegacy2
Omegacy2 Oct. 4 at 1:12 PM
$LLY i now 839.9s. as i pt 800+. i called it for a bounce few weeks ago at 639.
0 · Reply
3DBuilds
3DBuilds Oct. 4 at 10:42 AM
$JNJ $LLY $BMY $PGHL.NSE $PFE The Future is here 💯 🌎 💰
0 · Reply
Latest News on LLY
Pharmaceutical Stocks: Valuations And Pipelines Are Only Beginning To Be Appreciated

Oct 3, 2025, 4:20 PM EDT - 1 day ago

Pharmaceutical Stocks: Valuations And Pipelines Are Only Beginning To Be Appreciated

AZN NVO PFE

Top 50 High-Quality Dividend Growth Stocks For October 2025

Oct 3, 2025, 10:46 AM EDT - 1 day ago

Top 50 High-Quality Dividend Growth Stocks For October 2025

AAPL ACN ALLE AMAT APH CTAS DHI

Kernal Bio Joins Lilly Gateway Labs to Accelerate In Vivo Cell Therapies

Oct 3, 2025, 9:00 AM EDT - 1 day ago

Kernal Bio Joins Lilly Gateway Labs to Accelerate In Vivo Cell Therapies

Buy LLY Stock At $820?

Oct 3, 2025, 8:35 AM EDT - 1 day ago

Buy LLY Stock At $820?

How I Would Build An Ultra-High-Conviction Retirement Portfolio Right Now

Oct 3, 2025, 7:30 AM EDT - 1 day ago

How I Would Build An Ultra-High-Conviction Retirement Portfolio Right Now

AM CBOE CGDV CSWC DIVO ELS EME

Why Eli Lilly Is The Lion's Share Of My Portfolio

Oct 2, 2025, 11:26 PM EDT - 1 day ago

Why Eli Lilly Is The Lion's Share Of My Portfolio

These high-quality stocks are helping this large-cap Janus mutual fund beat its peers

Oct 2, 2025, 12:04 PM EDT - 2 days ago

These high-quality stocks are helping this large-cap Janus mutual fund beat its peers

APH GOOG GOOGL MSFT NVDA RCL

ABBV Stock vs. Eli Lilly & Merck

Oct 2, 2025, 8:20 AM EDT - 2 days ago

ABBV Stock vs. Eli Lilly & Merck

ABBV MRK

Novo, Lilly weight-loss drugs should be first option obesity treatments, European doctors say

Oct 2, 2025, 5:05 AM EDT - 2 days ago

Novo, Lilly weight-loss drugs should be first option obesity treatments, European doctors say

NVO

‘Fast Money' traders talk opportunities in health care stocks

Oct 1, 2025, 5:48 PM EDT - 2 days ago

‘Fast Money' traders talk opportunities in health care stocks

AMGN BIIB BMY IBB MRK MRNA PFE

Top Stock Movers Now: Nike, Eli Lilly, Corteva, AES, and More

Oct 1, 2025, 1:30 PM EDT - 3 days ago

Top Stock Movers Now: Nike, Eli Lilly, Corteva, AES, and More

AES CTVA NKE

Pfizer's TrumpRx Pact Sends Shockwaves: Why UnitedHealth, Lilly And CVS Can't Look Away

Oct 1, 2025, 10:49 AM EDT - 3 days ago

Pfizer's TrumpRx Pact Sends Shockwaves: Why UnitedHealth, Lilly And CVS Can't Look Away

CVS PFE UNH

Drug-Pricing Deals And Discounted Bets: Why LLY Stock Is A Core Pick In Our Top 10

Oct 1, 2025, 8:25 AM EDT - 3 days ago

Drug-Pricing Deals And Discounted Bets: Why LLY Stock Is A Core Pick In Our Top 10

Eli Lilly in negotiations with Trump administration for the next pharma deal

Sep 30, 2025, 3:12 PM EDT - 4 days ago

Eli Lilly in negotiations with Trump administration for the next pharma deal

Eli Lilly: Strong Buy On Sustained Growth, Expanding Moat, And Pipeline Depth

Sep 29, 2025, 10:26 AM EDT - 5 days ago

Eli Lilly: Strong Buy On Sustained Growth, Expanding Moat, And Pipeline Depth

LLY Stock Set For A 20% Breakout?

Sep 29, 2025, 9:35 AM EDT - 5 days ago

LLY Stock Set For A 20% Breakout?

Novo, Lilly Weight-Loss Drugs May Help Alzheimer's Patients. What It Means for the Stocks.

Sep 29, 2025, 2:00 AM EDT - 5 days ago

Novo, Lilly Weight-Loss Drugs May Help Alzheimer's Patients. What It Means for the Stocks.

Pharma tariffs 'not a huge risk' for domestic companies, says Mizuho's Jared Holz

Sep 26, 2025, 6:39 PM EDT - 7 days ago

Pharma tariffs 'not a huge risk' for domestic companies, says Mizuho's Jared Holz

AZN MRK NVO PFE ROG

Many pharma companies already made U.S. investment promises, says Citi's Geoff Meacham

Sep 26, 2025, 4:50 PM EDT - 8 days ago

Many pharma companies already made U.S. investment promises, says Citi's Geoff Meacham

ABBV AMGN MRK

A New Prescription For Pain: Understanding Trump's 100% Pharma Tariff

Sep 26, 2025, 2:37 PM EDT - 8 days ago

A New Prescription For Pain: Understanding Trump's 100% Pharma Tariff

AZN NVO SNY

Pharma tariffs still have a lot of questions outstanding, says Bernstein's Courtney Breen

Sep 26, 2025, 1:47 PM EDT - 8 days ago

Pharma tariffs still have a lot of questions outstanding, says Bernstein's Courtney Breen

ABBV AMGN GILD MRK MRNA PFE

Portal Innovations' John Flavin: Tariffs on pharma could raise costs and delay drug access

Sep 26, 2025, 12:21 PM EDT - 8 days ago

Portal Innovations' John Flavin: Tariffs on pharma could raise costs and delay drug access

ABBV MRK PFE BIIB BMY

Lilly opens newest Gateway Labs site in San Diego to boost local biotechnology ecosystem

Sep 26, 2025, 8:30 AM EDT - 8 days ago

Lilly opens newest Gateway Labs site in San Diego to boost local biotechnology ecosystem

Eli Lilly, Pfizer Stocks Rise After Trump's 100% Pharma Tariff Threat. Here's Why.

Sep 26, 2025, 8:15 AM EDT - 8 days ago

Eli Lilly, Pfizer Stocks Rise After Trump's 100% Pharma Tariff Threat. Here's Why.

PFE

Lilly's Kisunla (donanemab) receives marketing authorization by European Commission for the treatment of early symptomatic Alzheimer's disease

Sep 25, 2025, 6:39 PM EDT - 8 days ago

Lilly's Kisunla (donanemab) receives marketing authorization by European Commission for the treatment of early symptomatic Alzheimer's disease

US FDA approves Eli Lilly's therapy for metastatic breast cancer

Sep 25, 2025, 2:18 PM EDT - 9 days ago

US FDA approves Eli Lilly's therapy for metastatic breast cancer

U.S. FDA approves Inluriyo (imlunestrant) for adults with ER+, HER2-, ESR1-mutated advanced or metastatic breast cancer

Sep 25, 2025, 2:01 PM EDT - 9 days ago

U.S. FDA approves Inluriyo (imlunestrant) for adults with ER+, HER2-, ESR1-mutated advanced or metastatic breast cancer

Eli Lilly and Company (LLY) Presents at Bernstein 2nd Annual Global Healthcare Conference Transcript

Sep 25, 2025, 11:27 AM EDT - 9 days ago

Eli Lilly and Company (LLY) Presents at Bernstein 2nd Annual Global Healthcare Conference Transcript

Eli Lilly: Buying The Dip With Confidence

Sep 25, 2025, 10:53 AM EDT - 9 days ago

Eli Lilly: Buying The Dip With Confidence

Eli Lilly halts trial of experimental weight-loss drug

Sep 25, 2025, 6:47 AM EDT - 9 days ago

Eli Lilly halts trial of experimental weight-loss drug

Lilly plans to launch its experimental weight-loss pill in India, exec says

Sep 25, 2025, 1:12 AM EDT - 9 days ago

Lilly plans to launch its experimental weight-loss pill in India, exec says

The Big 3: AVGO, LLY, GS

Sep 24, 2025, 12:30 PM EDT - 10 days ago

The Big 3: AVGO, LLY, GS

AVGO GS

Eli Lilly's boss calls UK the 'worst' European country for drug prices

Sep 24, 2025, 4:12 AM EDT - 10 days ago

Eli Lilly's boss calls UK the 'worst' European country for drug prices

Eli Lilly to Build $6.5 Billion Ingredient-Manufacturing Facility in Texas

Sep 23, 2025, 1:31 PM EDT - 11 days ago

Eli Lilly to Build $6.5 Billion Ingredient-Manufacturing Facility in Texas

Eli Lilly to make weight-loss pill in new $6.5 billion Texas plant

Sep 23, 2025, 1:03 PM EDT - 11 days ago

Eli Lilly to make weight-loss pill in new $6.5 billion Texas plant

Eli Lilly to build $6.5 billion Texas manufacturing facility for obesity pill, other drugs

Sep 23, 2025, 1:00 PM EDT - 11 days ago

Eli Lilly to build $6.5 billion Texas manufacturing facility for obesity pill, other drugs

Lilly plans to build a new $6.5 billion facility to manufacture active pharmaceutical ingredients in Texas

Sep 23, 2025, 1:00 PM EDT - 11 days ago

Lilly plans to build a new $6.5 billion facility to manufacture active pharmaceutical ingredients in Texas

Boys & Girls Clubs of America Receives $10 Million Grant from Lilly Endowment Inc. to Help Transform the Future of Youth Programs in and Around Native Communities

Sep 23, 2025, 8:05 AM EDT - 11 days ago

Boys & Girls Clubs of America Receives $10 Million Grant from Lilly Endowment Inc. to Help Transform the Future of Youth Programs in and Around Native Communities

Celltrion unit pays $330 million for Eli Lilly production facility, filing shows

Sep 22, 2025, 9:32 PM EDT - 11 days ago

Celltrion unit pays $330 million for Eli Lilly production facility, filing shows

These are the top 22 stocks pushing the S&P 500 into record territory — and it's not all Big Tech

Sep 22, 2025, 3:37 PM EDT - 12 days ago

These are the top 22 stocks pushing the S&P 500 into record territory — and it's not all Big Tech

AAPL ABBV AMZN AVGO COST GOOG GOOGL

LLY & NVO Lead "Very Early Stages" of GLP-1 Market, PFE Reenters

Sep 22, 2025, 3:10 PM EDT - 12 days ago

LLY & NVO Lead "Very Early Stages" of GLP-1 Market, PFE Reenters

NVO

Eli Lilly: Orforglipron Sets Path Of Continued Revenue Growth In T2D And Obesity

Sep 21, 2025, 8:44 AM EDT - 13 days ago

Eli Lilly: Orforglipron Sets Path Of Continued Revenue Growth In T2D And Obesity

Inside the Race to Launch GLP-1 Weight-Loss Pills

Sep 19, 2025, 10:34 AM EDT - 15 days ago

Inside the Race to Launch GLP-1 Weight-Loss Pills

NVO

Hims & Hers, Eli Lilly, Novo Nordisk Face FDA Scrutiny: What It Means For Weight-Loss ETFs

Sep 18, 2025, 11:51 AM EDT - 16 days ago

Hims & Hers, Eli Lilly, Novo Nordisk Face FDA Scrutiny: What It Means For Weight-Loss ETFs

HIMS NVO PTH THNR HEAL

No more need for needles: A new generation of GLP-1 weight-loss drugs in pill form is coming closer

Sep 18, 2025, 10:00 AM EDT - 16 days ago

No more need for needles: A new generation of GLP-1 weight-loss drugs in pill form is coming closer

NVO

Novo Nordisk's Wegovy Outperforms Eli Lilly's Tirzepatide In Reducing Risk Of Heart Attack, Stroke, And Death: Study

Sep 18, 2025, 8:57 AM EDT - 16 days ago

Novo Nordisk's Wegovy Outperforms Eli Lilly's Tirzepatide In Reducing Risk Of Heart Attack, Stroke, And Death: Study

NVO

Novo Nordisk Stock Jumps. New Ozempic Data for Seniors Beats Rival Eli Lilly Medicine.

Sep 18, 2025, 6:10 AM EDT - 16 days ago

Novo Nordisk Stock Jumps. New Ozempic Data for Seniors Beats Rival Eli Lilly Medicine.

NVO

Market delayed in reaction to Novo Nordisk and Eli Lilly' s GLP-1 pills, says Mizuho's Jared Holz

Sep 17, 2025, 6:14 PM EDT - 16 days ago

Market delayed in reaction to Novo Nordisk and Eli Lilly' s GLP-1 pills, says Mizuho's Jared Holz

NVO

Lilly's Mounjaro helps improve blood sugar control in children in late-stage trial

Sep 17, 2025, 6:04 PM EDT - 16 days ago

Lilly's Mounjaro helps improve blood sugar control in children in late-stage trial

Lilly's Mounjaro (tirzepatide), a GIP/GLP-1 dual receptor agonist, reduced A1C by an average of 2.2% in a Phase 3 trial of children and adolescents with type 2 diabetes

Sep 17, 2025, 6:01 PM EDT - 16 days ago

Lilly's Mounjaro (tirzepatide), a GIP/GLP-1 dual receptor agonist, reduced A1C by an average of 2.2% in a Phase 3 trial of children and adolescents with type 2 diabetes

TalkMarkets
TalkMarkets Oct. 4 at 8:00 PM
Viking Therapeutics #Stock: A Stumble Or The #Setup Of The Decade? $LLY $NVO $VKTX Also $MRK $PFE https://talkmarkets.com/content/stocks--equities/viking-therapeutics-stock-a-stumble-or-the-setup-of-the-decade?post=526441&userid=123969
0 · Reply
Skipper6
Skipper6 Oct. 4 at 6:31 PM
$VKTX ...Lilly needs to buy Viking and get it over with, they'll be kicking themselves if someone else grabs them! $LLY share price will double and they will quickly be a trillion dollar mc business!! Go Viking!
0 · Reply
GreenEnergy2022
GreenEnergy2022 Oct. 4 at 4:42 PM
$ALT The cT1 data we presented was extremely good! $MDGL $LLY $AKRO
0 · Reply
MyDynastyLife
MyDynastyLife Oct. 4 at 3:35 PM
$LLY ❤️ this ticker
1 · Reply
Blueville
Blueville Oct. 4 at 3:09 PM
$HOOD $LLY $TSLA The top performing options lottos of the week from Sept 29 - Oct 3. #ConsistentProfits #BluevilleCapital
0 · Reply
Synaptric
Synaptric Oct. 4 at 2:37 PM
$NOW $TMO $LLY $META $PEP Year-to-date high in above-cloud count. The week’s developments highlight a constructive underlying message: rotation into new sectors is broadening leadership and reinforcing structural strength across the market. With healthcare joining technology in driving gains, the Cloud Watch indicators suggest resilience remains the defining feature of this rally.
0 · Reply
ChartGuysDan
ChartGuysDan Oct. 4 at 2:20 PM
XBI XLV seeing rotation. Trump tipping Off Trades. Scouting swing shorts in quantum. https://www.chartguys.com/watch?v=FEatasR0T1I $QBTS $RGTI $TSLA $LLY $SLV
0 · Reply
Synaptric
Synaptric Oct. 4 at 2:05 PM
$NOW $TMO $LLY $META $PEP U.S. equities resumed their advance this week, with the NASDAQ 100 rising 1.2% and the S&P 500 gaining 1.1%. Investors looked past headlines and instead embraced a mix of optimism, deal activity, and sector rotation. Notably, the Cloud Watch breadth measure climbed to a year-to-date high, with 22 constituents now trading above their weekly Ichimoku Clouds. This rising count underscores a broad structural resilience that continues to underpin the market. Rotation into healthcare stood out as a defining theme. Eli Lilly and Thermo Fisher Scientific both vaulted from below-cloud to above-cloud status, reflecting investor enthusiasm for the sector. Such rotation is an encouraging sign of market health, as leadership expands beyond the usual names. Subscribe here: .https://cloudwatch.beehiiv.com/subscribe. https://cloudwatch.beehiiv.com/p/market-rotation-signals-broad-structural-strength-cloud-watch-10-3-25
0 · Reply
Omegacy2
Omegacy2 Oct. 4 at 1:12 PM
$LLY i now 839.9s. as i pt 800+. i called it for a bounce few weeks ago at 639.
0 · Reply
3DBuilds
3DBuilds Oct. 4 at 10:42 AM
$JNJ $LLY $BMY $PGHL.NSE $PFE The Future is here 💯 🌎 💰
0 · Reply
LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 4 at 8:12 AM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $LLY Current Share Price: $839.87 Contracts: $LLY December 18, 2026 $840 Calls Scale in: $120.84- $147.69 Scale out: $187.97-$241.68 Can Easily Capture: 60% ROI Blended DTE: 441 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
BrianSJKim
BrianSJKim Oct. 4 at 4:36 AM
Good evening Holding calls in $UNH $TSLA $LLY this weekend Enjoy $SPY $QQQ
0 · Reply
WAJeff
WAJeff Oct. 4 at 1:05 AM
$LLY Imagine being this wrong this often. We need an inverse @HAL9000x etf, just around the things he’s bearish about
1 · Reply
StageAnalysis
StageAnalysis Oct. 3 at 11:24 PM
Stage Analysis Screener – Stage 2 Breakouts, Transitions & Continuation Breakouts AZN, RHHBY, FORM, $PFE, $TMO, IRM, K, RGEN, BRSL, $LLY, LW, $MRVL, ONTO, REYN, DHR, AAON, LVMUY, TECH, EG, MRK, STLA Filters: Stage: 2A, 2, 2B Stage Change: Stage Changed Market Cap: +Mini (over $300MLN) WCR: Close in Upper Quarter of Bar Avg $ Volume: Over 100M Sort order: Sector / Sub-industry The purpose of this scan is to find stocks whose major Stage changed this week to Stage 2 from either Stage 1,3 or 4.
0 · Reply
Ztrader26
Ztrader26 Oct. 3 at 10:46 PM
$LLY $CNC you guys think lly is cheap. PE on cnc is too good healthcare name
0 · Reply
aymzaue5218u
aymzaue5218u Oct. 3 at 10:11 PM
$LLY $PFE Why Shares of Eli Lilly Soared This Week Pfizer The company's multibillion-dollar U.S. manufacturing investments will likely be welcomed by the Trump administration. Eli Lilly's management has committed to lowering drug prices in the U.S.
0 · Reply
Noneyabizness
Noneyabizness Oct. 3 at 10:10 PM
$LLY back to $1000 next week! This momentum is just getting started. Probably a lot of FOMO here
1 · Reply
Tinderbox
Tinderbox Oct. 3 at 8:57 PM
$LLY $PFE Why Shares of Eli Lilly Soared This Week Pfizer The company's multibillion-dollar U.S. manufacturing investments are likely welcomed by the Trump administration. Eli Lilly's management has committed to lowering U.S. drug prices.
0 · Reply
frozengate
frozengate Oct. 3 at 8:43 PM
$LLY been riding call options since last week and still riding with house money. My 4K turning to 35k and this thing gonna be ATH before month is over. If i can flip 100K I'm gonna buy FIFA Final ticket for next year. Good luck next week. $COIN
0 · Reply
SPYmyQQQ
SPYmyQQQ Oct. 3 at 8:40 PM
🏛️ 🚀 $LLY up ⬆️13.03% since our entry $750.37 on Sep 22, 2025 👉 FREE TRIAL! spymyqqq.com/join/ Time-stamped signals. NO B.S.!
0 · Reply
notreload_ai
notreload_ai Oct. 3 at 8:26 PM
$HIMS, $NVO ... Novo Nordisk is planning a strategic digital launch for its forthcoming obesity pill, targeting telehealth sites like Ro and WeightWatchers in early 2026 to recapture market share lost to rival $LLY and combat the rise of copycat drugs. https://notreload.xyz/novo-nordisk-telehealth-strategy-weight-loss-pill/
0 · Reply
Vertical_Capital
Vertical_Capital Oct. 3 at 8:04 PM
$CRMD IT'S ABOUT TO HAPPEN!!! PARABOLIC PEOPLE!!! LOAD $QUBT $META $LLY $AMZN
1 · Reply